Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Steady performance in the SES business, the acquisition of 1 subsidiary in the previous fiscal year, an increase in the number of prescriptions filled, and efforts to reduce selling, general and administrative expenses. The telecommunications business was affected by intensified competition with rival companies.
No applicable matters (the note on the going concern assumption states that there are no applicable matters)
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥2,149 million (YoY +8.5%) |
| Operating profit | ¥66 million (YoY +160.2%) |
| Ordinary income | ¥59 million (YoY +167.1%) |
| Profit attributable to owners of the parent | ¥11 million (YoY +13.7%) |
| Net income per share | ¥2.39 |
| Equity ratio | End of the current fiscal period 42.3 / End of previous period 41.5 |
| Total assets | ¥7,100 million |
| Net assets | ¥3,005 million |
| Cash and cash equivalents at end of period | ¥2,052,486 thousand |
| Full-year earnings forecast | Net Sales ¥8,928 million (YoY +7.2%) / Operating profit ¥159 million / Ordinary income ¥128 million / Net income ¥7 million |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Segment revenue | Internet-related business ¥376 million (YoY +42.0%), Telecommunications Business ¥58 million (YoY +11.8%), Dispensing pharmacies and related businesses ¥1,721 million (YoY +2.7%) |
| Segment profit | Internet-related business ¥14 million (YoY +69.9%), Telecommunications Business ¥6 million (YoY +71.2%), Dispensing pharmacies and related businesses ¥154 million (YoY +23.1%) |
| Depreciation and amortization | ¥32,905 thousand |
| Disclosure regarding the going concern assumption | No applicable matters (the note on the going concern assumption states that there are no applicable matters) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 4,677,720 shares |
| Treasury Shares at Period-End | 49,050 shares |
| Factors Behind Changes in Business Performance | Steady performance in the SES business, the acquisition of 1 subsidiary in the previous fiscal year, an increase in the number of prescriptions filled, and efforts to reduce selling, general and administrative expenses. The telecommunications business was affected by intensified competition with rival companies. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Results benefited from rising demand for IT engineers driven by DX initiatives, steady performance in the SES business, the acquisition of 1 subsidiary in the previous fiscal year, an increase in the number of prescriptions filled, and efforts to reduce selling, general and administrative expenses. The telecommunications business, however, was affected by intensified competition with rival companies.